Caribou BiosciencesCRBU

Caribou Biosciences

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPRplatform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Rachel Haurwitz, PhD

$268.2M

Market Cap • 24/05/2024

2011

(há 13 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Berkeley

Sede • California

137

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CRBUSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-4%

1 dia

21/05/2024

-12%

1 semana

17/05/2024

-23%

1 mês

24/04/2024

-35%

1 ano

24/05/2023

10 anos

Histórico